BTS
VRTX icon

BB&T Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

BB&T Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.36M Sell
7,944
-894
-10% -$158K 0.01% 691
2019
Q2 		$1.62M Buy
8,838
+630
+8% +$110K 0.01% 648
2019
Q1 		$1.51M Buy
8,208
+586
+8% +$108K 0.01% 664
2018
Q4 		$1.26M Buy
7,622
+234
+3% +$40.5K 0.01% 672
2018
Q3 		$1.42M Buy
7,388
+328
+5% +$58.4K 0.01% 706
2018
Q2 		$1.2M Sell
7,060
-896
-11% -$139K 0.01% 746
2018
Q1 		$1.3M Sell
7,956
-1,704
-18% -$278K 0.01% 697
2017
Q4 		$1.45M Buy
9,660
+127
+1% +$18.8K 0.02% 626
2017
Q3 		$1.45M Sell
9,533
-3,089
-24% -$465K 0.02% 623
2017
Q2 		$1.63M Buy
12,622
+723
+6% +$87K 0.02% 575
2017
Q1 		$1.3M Buy
11,899
+5,002
+73% +$440K 0.02% 571
2016
Q4 		$601K Hold
6,897
– – 0.01% 777
2016
Q3 		$601K Buy
6,897
+185
+3% +$17.5K 0.01% 777
2016
Q2 		$577K Buy
6,712
+752
+13% +$65K 0.01% 759
2016
Q1 		$473K Buy
5,960
+591
+11% +$53.5K 0.01% 789
2015
Q4 		$675K Sell
5,369
-750
-12% -$90.5K 0.01% 633
2015
Q3 		$637K Buy
6,119
+802
+15% +$103K 0.01% 626
2015
Q2 		$656K Buy
5,317
+477
+10% +$60.1K 0.01% 650
2015
Q1 		$571K Buy
4,840
+655
+16% +$78.5K 0.01% 676
2014
Q4 		$497K Buy
4,185
+633
+18% +$71.3K 0.01% 710
2014
Q3 		$399K Sell
3,552
-42
-1% -$4K 0.01% 757
2014
Q2 		$340K Buy
+3,594
New +$252K 0.01% 782

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BB&T Securities's VRTX Position: Q3 2019 in Review

BB&T Securities reduced its Vertex Pharmaceuticals (VRTX) stake by 10% in Q3 2019, selling an estimated $158K and leaving 7,944 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #691.

BB&T Securities first reported a position in VRTX in Q2 2014 and has held it in 22 quarters since. The position peaked at $1.63M in Q2 2017. 708 funds tracked by Wall St. Rank hold VRTX as of Q3 2019.

  • BB&T Securities held 7,944 shares of Vertex Pharmaceuticals worth $1.36M as of Q3 2019.
  • BB&T Securities sold 894 Vertex Pharmaceuticals shares in Q3 2019, an estimated $158K.
  • Vertex Pharmaceuticals made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #691 holding.
  • BB&T Securities first reported a position in Vertex Pharmaceuticals in Q2 2014 and has held it in 22 quarters since.
  • BB&T Securities's Vertex Pharmaceuticals position peaked at $1.63M in Q2 2017.
  • 708 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.